Kilder

Andrikopoulou M, Purisch SE, Handal-Orefice R, Gyamfi-Bannerman C. Low-dose aspirin is associated with reduced spontaneous preterm birth in nulliparous women. Am J Obstet Gynecol. 2018;219(4):399.e1-399.e6. doi: 10.1016/j.ajog.2018.06.011. 

Arnone D, Omar O, Arora T, Östlundh L, Ramaraj R, Javaid S, Govender RD, Ali BR, Patrinos GP, Young AH, Stip E. Effectiveness of pharmacogenomic tests including CYP2D6 and CYP2C19 genomic variants for guiding the treatment of depressive disorders: Systematic review and meta-analysis of randomised controlled trials. Neurosci Biobehav Rev. 2023;144:104965. doi: 10.1016/j.neubiorev.2022.104965. 

Bartz D, Chitnis T, Kaiser UB, Rich-Edwards JW, Rexrode KM, Pennell PB, Goldstein JM, O'Neal MA, LeBoff M, Behn M, Seely EW, Joffe H, Manson JE. Clinical advances in sex- and gender-informed medicine to improve the health of all: A review. JAMA Intern Med. 2020;180(4):574-583. doi: 10.1001/jamainternmed.2019.7194. 

Cammarota G, Ianiro G, Ahern A, Carbone C, Temko A, Claesson MJ, Gasbarrini A, Tortora G. Gut microbiome, big data and machine learning to promote precision medicine for cancer. Nat Rev Gastroenterol Hepatol. 2020;17(10):635-648. doi: 10.1038/s41575-020-0327-3. 

Cecchin E, Stocco G. Pharmacogenomics and personalized medicine. Genes (Basel). 2020;11(6):679. doi: 10.3390/genes11060679. 

Chakravarty D, Solit DB. Clinical cancer genomic profiling. Nat Rev Genet. 2021 Aug;22(8):483-501. 

Clinical Pharmacogenomics Implementation Consortium; CPIC (cpicpgx.org)

Currie G, Delles C. Precision medicine and personalized medicine in cardiovascular disease. Adv Exp Med Biol. 2018;1065:589-605. doi: 10.1007/978-3-319-77932-4_36. 

CYPinfo - Fortolkningsverktøy for farmakogenetiske analyser Oslo universitetssykehus; www.cypinfo.

Dacic S. State of the Art of Pathologic and Molecular Testing. Hematol Oncol Clin North Am. 2023;37(3):463-473. doi: 10.1016/j.hoc.2023.02.001.

Farmakologiportalen; https://farmakologiportalen.no/content/1/farmakologiportalen

US Food and Drug Administration (FDA). Table of Pharmacogenomic Biomarkers in Drug Labeling. https://www.fda.gov/drugs/science-and-research-drugs/table-pharmacogenomic-biomarkers-drug-labeling

Feng W, Liu J, Ao H, Yue S, Peng C. Targeting gut microbiota for precision medicine: Focusing on the efficacy and toxicity of drugs. Theranostics. 2020;10(24):11278-11301. doi: 10.7150/thno.47289.

Freidlin B, Allegra CJ, Korn EL. Moving Molecular Profiling to Routine Clinical Practice: A Way Forward? J Natl Cancer Inst. 2020;112(8):773-778. doi: 10.1093/jnci/djz240.

Helse- og omsorgsdepartementet. Strategi for persontilpasset medisin (2023). https://www.regjeringen.no/no/dokumenter/strategi-for-persontilpasset-medisin/id2959463/

Hills AP, Farpour-Lambert NJ, Byrne NM. Precision medicine and healthy living: The importance of the built environment. Prog Cardiovasc Dis. 2019;62(1):34-38. doi: 10.1016/j.pcad.2018.12.013. 

Kupka E, Hesselman S, Hastie R, Lomartire R, Wikstrom AK, Bergman L. Low-dose aspirin use in pregnancy and the risk of preterm birth: a Swedish register-based cohort study. Am J Obstet Gynecol. 2023;228(3):336.e1-336.e9. doi: 10.1016/j.ajog.2022.09.006.

Li X, Milosavljevic A, Elsea SH, Wang CC, Scaglia F, Syngelaki A, Nicolaides KH, Poon LC. Effective Aspirin Treatment of Women at Risk for Preeclampsia Delays the Metabolic Clock of Gestation.Hypertension. 2021;78(5):1398-1410. doi: 10.1161/HYPERTENSIONAHA.121.17448. 

International Consortium for Personalised Medicine. https://www.icpermed.eu/

Magee LA, Brown MA, Hall DR, Gupte S, Hennessy A, Karumanchi SA, Kenny LC, McCarthy F, Myers J, Poon LC, Rana S, Saito S, Staff AC, Tsigas E, von Dadelszen P. The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice. Pregnancy Hypertens. 202;27:148-169. doi: 10.1016/j.preghy.2021.09.008. 

Nasjonalt kompetansenettverk for persontilpasset medisin NorPrem. https://norprem.no/persontilpasset-medisin

Nicolaides KH, Syngelaki A, Poon LC, Rolnik DL, Tan MY, Wright A, Wright D. First-trimester prediction of preterm pre-eclampsia and prophylaxis by aspirin: Effect on spontaneous and iatrogenic preterm birth. BJOG. 2024;131(4):483-492. doi: 10.1111/1471-0528.17673. 

PERsonalised medicine trials (PERMIT). https://permit-eu.org/publications

Rolnik DL, Wright D, Poon LC, et al. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. N Engl J Med 2017; 377(7): 613-22.

Sadee W, Wang D, Hartmann K, Toland AE. Pharmacogenomics: Driving personalized medicine. Pharmacol Rev. 2023;75(4):789-814. doi: 10.1124/pharmrev.122.000810.

Sioud M, Melien Ø. Treatment options and individualized medicine. Methods Mol Biol. 2007;361:327-40.

Stachenfeld NS, Mazure CM. Precision medicine requires understanding how both sex and gender influence health. Cell. 2022;185(10):1619-1622. doi: 10.1016/j.cell.2022.04.012. 

Staff A, Kvie A, Langesæter E, Michelsen TM, Moe K, Strand KM Værnesbranden M, Øian P. Hypertensive svangerskapskomplikasjoner og eklampsi. Norsk gynekologisk forening Veileder i fødselshjelp. ePub. ISBN 978-82-692382-2-8. [hentet feb 2024]. Tilgjengelig fra: https://www.legeforeningen.no/foreningsledd/fagmed/norsk-gynekologisk-forening/veiledere/veileder-i-fodselshjelp/hypertensive-svangerskapskomplikasjoner-og-eklampsi/

Staff AC, Redman CW, Williams D, Leeson P, Moe K, Thilaganathan B, Magnus P, Steegers EAP, Tsigas EZ, Ness RB, Myatt L, Poston L, Roberts JM; Global Pregnancy Collaboration (CoLab). Pregnancy and long-term maternal cardiovascular health: Progress through harmonization of research cohorts and biobanks. Hypertension 2016; 67(2): 251-60.

Superchi C, Brion Bouvier F, Gerardi C, Carmona M, San Miguel L, Sánchez-Gómez LM, Imaz-Iglesia I, Garcia P, Demotes J, Banzi R, Porcher R; PERMIT Group. Study designs for clinical trials applied to personalised medicine: a scoping review. BMJ Open. 2022;12(5):e052926. doi: 10.1136/bmjopen-2021-052926. 

Taylor C, Crosby I, Yip V, Maguire P, Pirmohamed M, Turner RM. A review of the important role of CYP2D6 in pharmacogenomics. Genes (Basel). 2020;11(11):1295. doi: 10.3390/genes11111295. 

The Fetal Medicine Foundation. Risk assessment: Risk for preeclampsia. [hentet feb 2024]. https://fetalmedicine.org/research/assess/preeclampsia/first-trimester.

Tsimberidou AM, Kahle M, Vo HH, Baysal MA, Johnson A, Meric-Bernstam F. Molecular tumour boards - current and future considerations for precision oncology. Nat Rev Clin Oncol. 2023 Dec;20(12):843-863. 

Wahida A, Buschhorn L, Fröhling S, Jost PJ, Schneeweiss A, Lichter P, Kurzrock R. The coming decade in precision oncology: six riddles. Nat Rev Cancer. 2023 Jan;23(1):43-54. 

World Health Organization (WHO) Resolution WHA 75.8 (2022). Strengthening clinical trials1 to provide high-quality evidence on health interventions and to improve research quality and coordination. https://apps.who.int/gb/ebwha/pdf_files/WHA75/A75_R8-en.pdf

Yin, Q., Zhong, L., Song, Y. Bai l, Wang Z, Li C, Xu Y, Yang X. A decision support system in precision medicine: contrastive multimodal learning for patient stratification. Ann Oper Res (2023). https://doi.org/10.1007/s10479-023-05545-6

Zhang, Z., Lin, X. & Wu, S. A hybrid algorithm for clinical decision support in precision medicine based on machine learning. BMC Bioinformatics. 2023;24(1):3. doi: 10.1186/s12859-022-05116-9.https://doi.org/10.1186/s12859-022-05116-9